InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,022.21
(
-0.58%
)
US TECH 100
17,060.00
(
-1.07%
)
Dow Jones
37,753.31
(
-0.12%
)
Brent Oil
86.81
(
-0.21%
)
Bitcoin
61,592.68
(
0.51%
)
Post# of 91007
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MB25

Send PM Follow Ignore
Followers 23
Posts 3012
Boards Moderated 0
Alias Born 08/29/2007

MB25

Re: Turbomunkey post# 87217

Friday, 05/29/2015 8:48:17 AM

Friday, May 29, 2015 8:48:17 AM

Post# of 91007
Too bad he is not spending the time updating current shareholders on the status of this company's financials, debt level, share structure, patents, legal proceedings, and a host of other issues. I fully expect this interview to be nothing more than the other interviews he has done in the past. It is time for details regarding the business not another overview of autologous stromal vascular fraction cell therapy.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up